Coping with Complications that Occur after Prostate Biopsy for Satisfactory Evaluation of Call Service Using Artificial Intelligence: A Pilot Randomized Controlled Trial (doi:10.7910/DVN/ALVSGP)

View:

Part 1: Document Description
Part 2: Study Description
Part 5: Other Study-Related Materials
Entire Codebook

Coping with Complications that Occur after Prostate Biopsy for Satisfactory Evaluation of Call Service Using Artificial Intelligence: A Pilot Randomized Controlled Trial

doi:10.7910/DVN/ALVSGP

Harvard Dataverse

2024-11-20

1

Jae Heon Kim, 2024, "Coping with Complications that Occur after Prostate Biopsy for Satisfactory Evaluation of Call Service Using Artificial Intelligence: A Pilot Randomized Controlled Trial", https://doi.org/10.7910/DVN/ALVSGP, Harvard Dataverse, V1

Coping with Complications that Occur after Prostate Biopsy for Satisfactory Evaluation of Call Service Using Artificial Intelligence: A Pilot Randomized Controlled Trial

doi:10.7910/DVN/ALVSGP

Jae Heon Kim (Department of Urology, Soonchunhyang University Seoul Hospital)

Harvard Dataverse

Jae Heon Kim

Park, Hyun Jun

2024-11-20

https://doi.org/10.7910/DVN/ALVSGP

Medicine, Health and Life Sciences

Purpose: Purpose: To assess whether an artificial intelligence (AI)-based reassurance-call can inform patients about potential complica- tions and provides reassurance following a prostate biopsy. Materials and Methods: Materials and Methods: From October 2022 to December 2023, 42 patients aged 40 to 70 years undergoing their first pros- tate biopsy were recruited. The ‘Reassurance-call’ service was utilized to inform and monitor patients for complications. Participants were randomized into three groups: AI-assisted Reassurance-call service (Group 1), human-assisted Reassurance- call service (Group 2), and no call (Group 3). The primary outcome measured was patient satisfaction with the Reassurance- call service, assessed using a Likert scale. Secondary outcomes included satisfaction with complication management and anxiety levels, evaluated using the Likert scale, visual analog scale (VAS), and the state-trait anxiety inventory (STAI). Results: Results: Satisfaction with Reassurance-call averaged 4.20 (standard deviation [SD] 0.56) for Group 1 and 4.71 (SD 0.47) for Group 2, showing a statistically significant difference. Satisfaction regarding complication management using Likert scale was 4.13 (SD 0.52) for Group 1, 4.43 (SD 0.76) for Group 2, and 3.79 (SD 0.80) for Group 3 with no statistically significant differences. Satisfaction regarding complication management using VAS averaged 8.33 (SD 1.23) for Group 1, 8.57 (SD 1.45) for Group 2, and 7.07 (SD 1.86) for Group 3, indicating significant differences. Anxiety levels using STAI averaged 40.00 (SD 10.54) for Group 1, 39.14 (SD 8.29) for Group 2, and 35.00 (SD 9.46) for Group 3, showing no significant differences. Anxiety levels using VAS averaged 5.07 (SD 2.79) for Group 1, 2.21 (SD 2.64) for Group 2, and 3.50 (SD 2.28) for Group 3, with significant differences observed. Conclusions: Conclusions: AI demonstrated potential in enhancing patient reassurance and managing complications post-prostate biopsy, although human interaction proved superior in certain aspects. Further studies with larger cohorts are necessary to verify the effectiveness of AI-based tools.

pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health Published online M D, 2024 https://doi.org/10.5534/wjmh.240191

https://doi.org/10.5534/wjmh.240191

pISSN: 2287-4208 / eISSN: 2287-4690 World J Mens Health Published online M D, 2024 https://doi.org/10.5534/wjmh.240191

Label:

전체대상자list_20230906 (1) law data.xlsx

application/vnd.openxmlformats-officedocument.spreadsheetml.sheet